The full Interim report is available on Brighter's website www.brighter.se. The Interim report is also attached as a pdf file to this press release.
KSEK. Apr-Jun Apr-Jun Jan-Jun Jan-Jun Jan-Dec Jan-Dec
2018 2017 2018 2017 2017 2016
Operating profit -13,111 -4,766 -23,596 -8,401 -19,946 -18,501
Net financial items -1,218 -785 -1,219 -786 -2,897 -238
Profit before tax -15,496 6,503 -26,963 -11,340 -27,292 -14,683
Total assets 116,900 84,354 116,900 84,354 111,354 68,734
Equity per share (SEK) 1.16 1.02 1.16 1.02 1.35 1.01
Capital adequacy (%) 67% 79% 67% 79% 78% 76%
For definitions, see note 24 in Brighter's 2017 Annual Report.
Promising partnership in UAE initiated.
We kicked off Q2 on a strong note with Actiste winning the prestigious Red Dot Award for good design and quality. This is a fantastic independent confirmation of Actiste's stylish and user-friendly design, and it's very encouraging for our internal development team and our design and innovation partner Veryday. A big thank you to everyone involved!
There were two changes made to Brighter's Board of Directors at the annual general shareholders meeting during Q2. Barbro, one of Sweden's leading voices in healthcare, became the company's new chairperson. Barbro is a firm advocate for finding ways to encourage patient autonomy and serve people better with available healthcare resources, and her guidance will be very valuable as we continue to develop our business. Catarina Ihre also joined Brighter's board, bringing deep experience in investor relations from both the corporate and investor sides.
In April, Brighter was nominated as a "Rising Star" by trade association Swecare, which works to help Swedish healthcare companies expand internationally. As with the Red Dot Award, the Swecare nomination is further confirmation that Brighter is on the right track with our product and market vision.
In June, we made several announcements about the work we're doing to establish Brighter in Southeast Asia. We're now negotiating with pharmaceutical manufacturers in the region.
We're also negotiating with several parties in Thailand around the right to resell Actiste, so that we can broaden our reach in the region. We're in active discussions with additional sales partners in Indonesia too.
During the year discussions have been on going in several interesting markets. The partnership between Brighter and AFAQ Group L.L.C. is certainly one of Brighters more promising market breakthroughs lately. In July Brighter entered into a partnership to establish a company based in the United Arab Emirates and introduce Actiste® Diabetes Management as a Service into the Gulf Co-operation Council (G.C.C.) region. AFAQ Group is committed to the success of Brighter in the Arab region and we look forward to working with them and contributing to the improvement of the regions vast diabetes problem.
Finally towards the end of the quarter, Brighter was selected as one of the finalists in the Serendipity Challenge 2018 - a competition for the most promising startups and growth companies in the Nordics. The competition aims to recognize entrepreneurial companies with unique innovation or business concepts that have the potential to be commercialized on the global market. It was a great honor for Brighter to be selected and yet another sign of external recognition for our vision.
Truls Sjöstedt, Founder and CEO of Brighter AB
Interim report Jul-Sept 2018: 11/15/2018
Interim report Oct-Dec 2018: 27/2/2019
Annual Report 2018: 27/3/2019
Annual General Meeting: 9/5/2019
For further questions. Please contact:
Truls Sjöstedt, CEO
Phone: +46 709 73 46 00
Ann Zetterberg, CFO
Phone: +46 708 37 21 23
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare's biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se
The Company's shares are listed on NASDAQOMX First North/BRIG (http://www.nasdaqomxnordic.com/shares/microsite?Instrument=SSE86375). Brighter's Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 - 684 211 00, email@example.com, www.eminova.se.
This information is such information, as Brighter AB is required to disclose under the EU Market Abuse Regulation and the Securities Market Act. The information was provided by the above contact persons for publication on August 24, 2018 at. 13:00 CET.
This information was distributed by Cision http://www.cisionwire.se/